The invention relates to methods and uses of modulating fetal hemoglobin expression (HbF) in a hematopoietic progenitor cells via inhibitors of BCL11A expression or activity, such as RNAi and antibodies.

Edits on 2 Oct, 2023

"Add patent inventor(s)"

Golden AI

edited on 2 Oct, 2023

Edits made to:

Infobox (+2 properties)

Infobox

Patent Inventor Names

Stuart H. Orkin0

Vijay G. Sankaran0

Edits on 21 Jul, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 21 Jul, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=102668260

Edits on 22 Sep, 2022

"Entity importer update"

Golden AI

edited on 22 Sep, 2022

Infobox

Is a

Patent

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

102668260

Date of Patent

April 23, 2019

Patent Application Number

158883500

Date Filed

February 5, 2018

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=102668260

Patent Primary Examiner

‌

Sean McGarry

Edits on 18 Jun, 2022

"Entity importer update"

Golden AI

edited on 18 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=10266826

Edits on 25 Jan, 2022

"Created via: Entity Importer"

Golden AI

created this topic on 25 Jan, 2022

Edits made to:

Infobox (+7 properties)

‌

US Patent 10266826 Modulation of BCL11A for treatment of hemoglobinopathies

Infobox

Is a

Patent

Patent jurisdiction

United States Patent and Trademark Office

Patent number

10266826

Date of patent

April 23, 2019

Patent application number

15888350

Date Filed

February 5, 2018

Patent primary examiner

‌

Sean McGarry

Find more entities like US Patent 10266826 Modulation of BCL11A for treatment of hemoglobinopathies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API